Shire PLC Company Profile (NASDAQ:SHPG)

About Shire PLC (NASDAQ:SHPG)

Shire PLC logoShire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SHPG
  • CUSIP: N/A
  • Web: www.shire.com
Capitalization:
  • Market Cap: $46.32 billion
  • Outstanding Shares: 297,854,000
Average Prices:
  • 50 Day Moving Avg: $153.05
  • 200 Day Moving Avg: $168.42
  • 52 Week Range: $139.36 - $209.22
P/E:
  • Trailing P/E Ratio: 69.65
  • Foreward P/E Ratio: 9.55
  • P/E Growth: 0.87
Sales & Book Value:
  • Annual Revenue: $14.58 billion
  • Price / Sales: 3.18
  • Book Value: $103.48 per share
  • Price / Book: 1.50
Dividend:
  • Annual Dividend: $0.92
  • Dividend Yield: 0.6%
Profitability:
  • EBIDTA: $5.76 billion
  • Net Margins: 4.70%
  • Return on Equity: 14.10%
  • Return on Assets: 6.25%
Debt:
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 0.96%
  • Quick Ratio: 0.52%
Misc:
  • Average Volume: 1.38 million shs.
  • Beta: 1.61
  • Short Ratio: 0.76
 

Frequently Asked Questions for Shire PLC (NASDAQ:SHPG)

What is Shire PLC's stock symbol?

Shire PLC trades on the NASDAQ under the ticker symbol "SHPG."

How often does Shire PLC pay dividends? What is the dividend yield for Shire PLC?

Shire PLC declared a semiannual dividend on Friday, August 11th. Investors of record on Friday, September 8th will be given a dividend of $0.1527 per share on Friday, October 20th. This represents a dividend yield of 0.21%. The ex-dividend date is Thursday, September 7th. View Shire PLC's Dividend History.

How were Shire PLC's earnings last quarter?

Shire PLC (NASDAQ:SHPG) released its quarterly earnings results on Friday, October, 27th. The company reported $3.37 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $3.66 by $0.29. Shire PLC had a net margin of 4.70% and a return on equity of 14.10%. View Shire PLC's Earnings History.

When will Shire PLC make its next earnings announcement?

Shire PLC is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for Shire PLC.

What guidance has Shire PLC issued on next quarter's earnings?

Shire PLC updated its FY17 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $14.80-15.20 for the period, compared to the Thomson Reuters consensus estimate of $14.85. The company issued revenue guidance of $14.9-15.3 billion, compared to the consensus revenue estimate of $15.04 billion.

Where is Shire PLC's stock going? Where will Shire PLC's stock price be in 2017?

21 brokers have issued 1-year price targets for Shire PLC's shares. Their forecasts range from $159.00 to $325.00. On average, they expect Shire PLC's share price to reach $220.91 in the next year. View Analyst Ratings for Shire PLC.

What are analysts saying about Shire PLC stock?

Here are some recent quotes from research analysts about Shire PLC stock:

  • 1. Cantor Fitzgerald analysts commented, "This morning, SHPG announced that the Marketing Authorization Application (MAA) for Lifitegrast has been validated by the UK as the Reference Member State involved in the Decentralized Procedure (DCP)." (8/15/2017)
  • 2. According to Zacks Investment Research, "Shire reported encouraging Q2 results, beating estimates for both sales and earnings.The approval of Mydayis is likely to boost Shire’s ADHD segment dominance while strong performance of Vyvanse, Cinryze and Elaprase will continue to drive Shire’s top line. The label expansion of Cinryze in paediatrics and conditional approval of Natpara in Europe should continue to drive the top line going ahead. The hematology and immunology segment, acquired from Baxalta, gave a major boost to product sales. The approval of Xiidra has boosted the company’s ophthalmology space, acquiring roughly 23% of the total market by the end of Jun 2017. The Dyax acquisition has integrated well and Shire announced positive results from the phase III trial on lanadelumab in May 2017. However, the adult ADHD space is one of the largest and fastest growing segments of the market but is highly genericized. Moreover, shares have underperformed the industry." (8/8/2017)
  • 3. Jefferies Group LLC analysts commented, "SHPG posted strong 4Q16 revs ($3.8B vs $3.7B JEF) and EPS ($3.37 vs $3.26 JEF) as nearly all core franchises performed well. In particular, GI and Orphan Diseases showed strength. As for legacy BXLT, Immunoglobulins and Hemophilia performed well while Inhibitors lagged. We like the setup for 2017. If mgt executes on core brands, the Xiidra launch, and the BXLT integration, we could envision share price outperformance, augmented by significant deleveraging." (2/17/2017)

Are investors shorting Shire PLC?

Shire PLC saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 1,535,236 shares, an increase of 32.5% from the August 15th total of 1,158,579 shares. Based on an average trading volume of 1,336,807 shares, the days-to-cover ratio is presently 1.1 days.

Who are some of Shire PLC's key competitors?

Who are Shire PLC's key executives?

Shire PLC's management team includes the folowing people:

  • Flemming Ornskov M.D., Chief Executive Officer, Executive Director
  • Jeffrey Poulton, Chief Financial Officer, Executive Director
  • Joanne Cordeiro, Chief Human Resource Officer
  • William Mordan, General Counsel, Company Secretary
  • Perry Sternberg, Head - U.S. Commercial
  • Kim Stratton, Head - International Commercial
  • Philip J. Vickers, Head - Research and Development
  • Matthew Walker, Head - Technical Operations
  • Susan Saltzbart Kilsby, Independent Non-Executive Chairman of the Board
  • Olivier Bohuon, Non-Executive Director

Who owns Shire PLC stock?

Shire PLC's stock is owned by a number of of institutional and retail investors. Top institutional investors include Jennison Associates LLC (0.00%), Maverick Capital Ltd. (0.00%), Glenview Capital Management LLC (0.00%), FMR LLC (0.53%), Ameriprise Financial Inc. (0.51%) and Vanguard Group Inc. (0.49%). View Institutional Ownership Trends for Shire PLC.

Who sold Shire PLC stock? Who is selling Shire PLC stock?

Shire PLC's stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, FMR LLC, Voya Investment Management LLC, Arrowstreet Capital Limited Partnership, BlackRock Inc., Sphera Funds Management LTD., Sei Investments Co. and Capital Fund Management S.A.. View Insider Buying and Selling for Shire PLC.

Who bought Shire PLC stock? Who is buying Shire PLC stock?

Shire PLC's stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Glenview Capital Management LLC, Northern Trust Corp, OZ Management LP, Maverick Capital Ltd., Harding Loevner LP, Ameriprise Financial Inc. and Farallon Capital Management LLC. View Insider Buying and Selling for Shire PLC.

How do I buy Shire PLC stock?

Shares of Shire PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Shire PLC's stock price today?

One share of Shire PLC stock can currently be purchased for approximately $155.51.


MarketBeat Community Rating for Shire PLC (NASDAQ SHPG)
Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  803 (Vote Outperform)
Underperform Votes:  336 (Vote Underperform)
Total Votes:  1,139
MarketBeat's community ratings are surveys of what our community members think about Shire PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Shire PLC (NASDAQ:SHPG) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $220.91 (42.05% upside)

Analysts' Ratings History for Shire PLC (NASDAQ:SHPG)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/14/2017Cantor FitzgeraldReiterated RatingBuy$222.00LowView Rating Details
8/16/2017Evercore ISIInitiated CoverageOutperform -> Outperform$196.00MediumView Rating Details
8/11/2017Barclays PLCDowngradeOverweight -> Equal WeightLowView Rating Details
8/9/2017Jefferies Group LLCReiterated RatingHold$216.00 -> $206.00LowView Rating Details
8/4/2017Royal Bank of CanadaSet Price TargetBuy$213.00LowView Rating Details
7/26/2017Piper Jaffray CompaniesSet Price TargetHold$159.00MediumView Rating Details
7/17/2017BTIG ResearchReiterated RatingBuy$242.00LowView Rating Details
7/13/2017Sanford C. BernsteinReiterated RatingMarket Perform$210.00LowView Rating Details
7/12/2017Stifel NicolausReiterated RatingBuy$245.00LowView Rating Details
7/6/2017HSBC Holdings plcUpgradeReduce -> HoldMediumView Rating Details
6/1/2017Liberum CapitalDowngradeBuy -> HoldLowView Rating Details
5/31/2017Cowen and CompanyReiterated RatingOutperform$325.00LowView Rating Details
4/17/2017Goldman Sachs Group, Inc. (The)Boost Price TargetOverweight$202.00 -> $214.00LowView Rating Details
2/17/2017GuggenheimReiterated RatingNeutralN/AView Rating Details
12/2/2016Societe GeneraleInitiated CoverageBuyN/AView Rating Details
11/14/2016Leerink SwannSet Price TargetBuy$198.00N/AView Rating Details
11/7/2016J P Morgan Chase & CoReiterated RatingOverweightN/AView Rating Details
11/3/2016Citigroup Inc.Reiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
10/23/2016BNP ParibasReiterated RatingBuyN/AView Rating Details
10/8/2016Shore CapitalReiterated RatingBuyN/AView Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightN/AView Rating Details
5/23/2016Bryan, Garnier & CoInitiated CoverageBuyN/AView Rating Details
3/30/2016Bank of America CorporationReiterated RatingBuyN/AView Rating Details
2/13/2016Northland SecuritiesReiterated RatingBuyN/AView Rating Details
2/8/2016Susquehanna Bancshares IncLower Price TargetPositive$280.00 -> $220.00N/AView Rating Details
1/18/2016Credit Suisse GroupUpgradeBuyN/AView Rating Details
10/21/2015William BlairReiterated RatingOutperform$276.00N/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Shire PLC (NASDAQ:SHPG)
Earnings by Quarter for Shire PLC (NASDAQ:SHPG)
Earnings History by Quarter for Shire PLC (NASDAQ SHPG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2017$3.66$3.37ViewN/AView Earnings Details
8/3/20176/30/2017$3.53$3.73$3.75 billionViewListenView Earnings Details
5/2/2017Q1 17$3.22$3.63$3.57 billionViewListenView Earnings Details
2/16/2017Q416$3.24$3.37$3.78 billion$3.81 billionViewN/AView Earnings Details
11/1/2016Q316$3.21$3.17$3.57 billion$3.45 billionViewN/AView Earnings Details
8/2/2016Q216$3.03$3.38$2.28 billion$2.43 millionViewN/AView Earnings Details
4/29/2016Q1$3.05$3.19$1.71 billion$1.71 billionViewListenView Earnings Details
2/11/2016Q415$2.89$2.97$1.69 million$1.72 billionViewListenView Earnings Details
10/23/2015Q315$2.87$3.24$1.63 billion$1.58 billionViewListenView Earnings Details
7/23/2015Q215$2.81$2.63$1.59 billion$1.56 billionViewListenView Earnings Details
4/30/2015Q115$2.56$2.84$1.47 billion$1.49 billionViewN/AView Earnings Details
2/12/2015Q115$2.68$2.63$1.53 billion$1.58 billionViewN/AView Earnings Details
10/24/2014Q314$2.47$2.93$1.46 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$2.45$2.67$1.45 billion$1.50 billionViewN/AView Earnings Details
5/1/2014Q114$2.22$2.36$1.38 billion$1.35 billionViewN/AView Earnings Details
2/13/2014Q413$2.02$2.26$1.28 billion$1.33 billionViewN/AView Earnings Details
10/24/2013Q213$1.65$1.77$1.23 billion$1.24 billionViewN/AView Earnings Details
7/25/2013$1.60$1.79$1.21 billion$1.28 billionViewN/AView Earnings Details
5/2/2013Q113$1.56$1.63$1.21 billion$1.16 billionViewN/AView Earnings Details
2/14/2013Q412$1.58$1.58$1.20 billion$1.20 billionViewN/AView Earnings Details
10/25/2012$1.47$1.36ViewN/AView Earnings Details
8/1/2012$1.52$1.68ViewN/AView Earnings Details
4/26/2012$0.52$1.24ViewN/AView Earnings Details
2/9/2012$0.48$0.44ViewN/AView Earnings Details
10/28/2011$1.31$1.28ViewN/AView Earnings Details
7/28/2011$1.24$1.33ViewN/AView Earnings Details
4/28/2011$1.18$1.23ViewN/AView Earnings Details
2/10/2011$1.04$1.03ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Shire PLC (NASDAQ:SHPG)
2017 EPS Consensus Estimate: $14.74
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$3.22$3.36$3.31
Q2 20174$3.53$3.69$3.61
Q3 20174$3.59$3.89$3.73
Q4 20174$3.75$4.26$4.09
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Shire PLC (NASDAQ:SHPG)
Next Dividend:10/20/2017
Annual Dividend:$0.92
Dividend Yield:0.59%
Payout Ratio:41.07% (Trailing 12 Months of Earnings)
6.16% (Based on This Year's Estimates)
5.65% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Shire PLC (NASDAQ:SHPG)

Dividend History by Quarter for Shire PLC (NASDAQ SHPG)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/11/2017semiannual$0.150.21%9/7/20179/8/201710/20/2017
2/24/2017$0.773/8/20173/10/20174/25/2017
8/5/2016$0.149/7/20169/9/201610/7/2016
2/11/2016$0.673/9/20163/11/20164/12/2016
7/23/2015$0.139/2/20159/4/201510/2/2015
2/23/2015semiannual$0.570.48%3/11/20153/13/20154/14/2015
8/4/2014semiannual$0.110.09%9/3/20149/5/201410/3/2014
2/20/2014semiannual$0.510.61%3/5/20143/7/20144/8/2014
7/29/2013semiannual$0.090.16%9/4/20139/6/201310/3/2013
2/19/2013semiannual$0.440.92%3/6/20133/8/20134/9/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (NASDAQ:SHPG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Shire PLC (NASDAQ:SHPG)
Latest Headlines for Shire PLC (NASDAQ:SHPG)
Source:
DateHeadline
americanbankingnews.com logoShire PLC (SHPG) Sees Significant Increase in Short Interest
www.americanbankingnews.com - September 16 at 1:20 AM
americanbankingnews.com logoShire PLC (SHPG) Receives Buy Rating from Cantor Fitzgerald
www.americanbankingnews.com - September 15 at 3:36 PM
globenewswire.com logoShire Debuts MYDAYIS® and New Research at the 30th Annual Psych Congress
globenewswire.com - September 15 at 8:51 AM
seekingalpha.com logoShire to present research on recently approved ADHD med Mydayis at upcoming Psych Congress; shares up 2% premarket
seekingalpha.com - September 15 at 8:51 AM
finance.yahoo.com logoWhat’s Cooperman’s View on Shire?
finance.yahoo.com - September 15 at 8:51 AM
seekingalpha.com logoShire (SHPG) Presents at Morgan Stanley Global Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com - September 14 at 10:05 AM
streetinsider.com logoShire (SHPG) Says Phase 3 SAHARA Study Met Primary Endpoint (Earlier)
www.streetinsider.com - September 13 at 9:08 AM
investopedia.com logoLeon Cooperman: Stock Market Valuations Are 'Full But Fair'
www.investopedia.com - September 13 at 9:08 AM
prnewswire.com logoSmart Medical Device Could Save Millions of Lives
www.prnewswire.com - September 13 at 9:08 AM
americanbankingnews.com logoShire PLC (SHPG) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - September 12 at 4:48 PM
streetinsider.com logoShire (SHPG) Says Phase 3 SAHARA Study Met Primary Endpoint (Earlier) - StreetInsider.com
www.streetinsider.com - September 12 at 9:46 AM
seekingalpha.com logoLate-stage study assessing subcutaneous formulation of Shire's ... - Seeking Alpha
seekingalpha.com - September 12 at 9:46 AM
nasdaq.com logoInteresting SHPG Put And Call Options For January 2020 - Nasdaq
www.nasdaq.com - September 12 at 9:46 AM
nasdaq.com logoShire Plc Announces Fast Track Designation For SHP607 - Quick Facts - Nasdaq
www.nasdaq.com - September 12 at 9:45 AM
prnewswire.com logoDaily Technical Summary Reports on Healthcare Stocks -- Shire, Aerie Pharma, Heron Therapeutics, and United Therapeutics
www.prnewswire.com - September 11 at 6:49 AM
americanbankingnews.com logo$3.77 Billion in Sales Expected for Shire PLC (SHPG) This Quarter
www.americanbankingnews.com - September 9 at 5:42 AM
finance.yahoo.com logoHere's Why Shire PLC Stock Fell 10% in August
finance.yahoo.com - September 8 at 8:21 AM
fool.com logoHere's Why Shire PLC Stock Fell 10% in August
www.fool.com - September 7 at 2:01 PM
americanbankingnews.com logoValuEngine Lowers Shire PLC (SHPG) to Hold
www.americanbankingnews.com - September 2 at 3:04 PM
finance.yahoo.com logoCorporate News Blog - Sanofi Completes Acquisition of Vaccines Biotechnology Company, Protein Sciences
finance.yahoo.com - August 30 at 9:09 AM
americanbankingnews.com logoOpko Health (OPK) & Shire PLC (SHPG) Critical Survey
www.americanbankingnews.com - August 29 at 12:22 AM
nasdaq.com logoAnalysts Predict 16% Upside For PPH - Nasdaq
www.nasdaq.com - August 25 at 9:09 PM
seekingalpha.com logoRoche Is Almost At The Finish Line
seekingalpha.com - August 25 at 11:36 AM
streetinsider.com logoShire plc (SHPG) CFO Jeff Poulton to Leave at End of Year to Join Start-Up Indigo Ag - StreetInsider.com
www.streetinsider.com - August 23 at 11:35 AM
americanbankingnews.com logoShire PLC (SHPG) Given "Buy" Rating at Cantor Fitzgerald
www.americanbankingnews.com - August 21 at 3:28 PM
feeds.benzinga.com logoShire plc Director and Senior Management Changes
feeds.benzinga.com - August 21 at 10:21 AM
americanbankingnews.com logoShire PLC (SHPG) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - August 18 at 5:26 PM
nasdaq.com logoShire Files Marketing Application for Lifitegrast in Europe - Nasdaq ... - Nasdaq
www.nasdaq.com - August 17 at 4:37 PM
americanbankingnews.com logoShire PLC (SHPG) Research Coverage Started at Evercore ISI
www.americanbankingnews.com - August 16 at 6:26 PM
seekingalpha.com logoShire submits marketing application in Europe for lifitegrast for dry eye disease
seekingalpha.com - August 16 at 7:29 AM
finance.yahoo.com logoShire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe
finance.yahoo.com - August 16 at 7:29 AM
americanbankingnews.com logoShire PLC (SHPG) Earns "Buy" Rating from Cantor Fitzgerald
www.americanbankingnews.com - August 15 at 11:16 AM
finance.yahoo.com logoShire applies for European approval of potential blockbuster eye drop
finance.yahoo.com - August 15 at 6:56 AM
americanbankingnews.com logoShire PLC (NASDAQ:SHPG) Plans $0.15 Semiannual Dividend
www.americanbankingnews.com - August 11 at 6:06 PM
americanbankingnews.com logoShire PLC (NASDAQ:SHPG) Lowered to Equal Weight at Barclays PLC
www.americanbankingnews.com - August 11 at 4:04 PM
americanbankingnews.com logoShire PLC (NASDAQ:SHPG) to Post FY2017 Earnings of $15.04 Per Share, SunTrust Banks Forecasts
www.americanbankingnews.com - August 10 at 9:32 AM
nasdaq.com logoShire Becomes Oversold (SHPG) - Nasdaq
www.nasdaq.com - August 10 at 7:50 AM
americanbankingnews.com logoJefferies Group LLC Reaffirms "Hold" Rating for Shire PLC (SHPG)
www.americanbankingnews.com - August 9 at 3:26 PM
americanbankingnews.com logoFY2017 Earnings Forecast for Shire PLC (SHPG) Issued By Cantor Fitzgerald
www.americanbankingnews.com - August 9 at 8:36 AM
americanbankingnews.com logoSunTrust Banks Analysts Reduce Earnings Estimates for Shire PLC (SHPG)
www.americanbankingnews.com - August 9 at 7:26 AM
americanbankingnews.com logoShire PLC to Post Q4 2017 Earnings of $3.75 Per Share, William Blair Forecasts (SHPG)
www.americanbankingnews.com - August 7 at 8:02 AM
americanbankingnews.com logoShire PLC (SHPG) Forecasted to Earn Q2 2017 Earnings of $3.62 Per Share
www.americanbankingnews.com - August 7 at 7:04 AM
americanbankingnews.com logoShire PLC (SHPG) Given a $213.00 Price Target by Royal Bank Of Canada Analysts
www.americanbankingnews.com - August 6 at 7:08 PM
americanbankingnews.com logoShire PLC (NASDAQ:SHPG) Downgraded to "Strong Sell" at BidaskClub
www.americanbankingnews.com - August 5 at 11:04 AM
seekingalpha.com logoWhy Corporate Spinoffs For Shire And Valeant Make Sense - Seeking Alpha
seekingalpha.com - August 5 at 7:00 AM
seekingalpha.com logoShire Q2/2017: Market Reaction Makes No Sense - Seeking Alpha
seekingalpha.com - August 5 at 7:00 AM
americanbankingnews.com logoShire PLC (SHPG) Releases Earnings Results, Beats Expectations By $0.20 EPS
www.americanbankingnews.com - August 5 at 12:22 AM
americanbankingnews.com logoBrokers Set Expectations for Shire PLC's Q4 2017 Earnings (NASDAQ:SHPG)
www.americanbankingnews.com - August 4 at 2:38 PM
nasdaq.com logoEarnings Reaction History: Shire plc, 33.3% Follow-Through Indicator, 2.9% Sensitive - Nasdaq
www.nasdaq.com - August 4 at 8:10 AM
seekingalpha.com logoNo Room For Neuroscience In New-Look Shire - Seeking Alpha
seekingalpha.com - August 4 at 8:10 AM

Social

Chart

Shire PLC (SHPG) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff